Eurogentec enters in the Therapeutic Oligonucleotides Manufacturing Field

Products & Services

Combining over 30 years of expertise in oligonucleotide synthesis to 20 years of biopharmaceutical GMP manufacturing, we now offer GMP therapeutic oligonucleotides manufacturing for early clinical phases.

GMP certification by the Belgium Authorities for the manufacturing and quality control of therapeutic oligonucleotides according to ICH Q7 is planned for Q1 2019.

 

 

Attached Files

Trending Now

Products & Services

Evolution of Multiplex PCR: Benefits, Challenge...

Products & Services

Understanding quality grades in mRNA synthesis:...

Pichia pastoris: benefits and challenges in recombinant protein production

Previous post

Kaneka Eurogentec receives GMP accreditation for its new state-of-the-art facility in time for the production of DNA vaccines against COVID-19

Next post

Recommended for you

Pichia pastoris: benefits and challenges i..

Products & Services

This article will explore the advantages of using Pichia pastoris as an expression system, highlighting...
Continue Reading

Evolution of Multiplex PCR: Benefits, Chall..

Products & Services

Multiplex PCR is a powerful technique that enables the simultaneous detection of multiple genetic targets...
Continue Reading
12-13 June 2025

DATS

Groningen, NL

Eurogentec exhibits at "DATS"

@ Groningen, NL
Eurogentec is excited to announce our presence at the 4th Dutch Antisense Therapeutics Symposium, taking...
Continue Reading